LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. More Details
+ 1 more risk
Adequate balance sheet and overvalued.
Share Price & News
How has LBT Innovations's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: LBT's share price has been volatile over the past 3 months.
7 Day Return
AU Medical Equipment
1 Year Return
AU Medical Equipment
Return vs Industry: LBT exceeded the Australian Medical Equipment industry which returned 1.2% over the past year.
Return vs Market: LBT exceeded the Australian Market which returned -10.5% over the past year.
Price Volatility Vs. Market
How volatile is LBT Innovations's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall StShould You Worry About LBT Innovations Limited's (ASX:LBT) CEO Pay Cheque?
5 months ago | Simply Wall StCould The LBT Innovations Limited (ASX:LBT) Ownership Structure Tell Us Something Useful?
6 months ago | Simply Wall StThe LBT Innovations (ASX:LBT) Share Price Is Up 75% And Shareholders Are Holding On
Is LBT Innovations undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate LBT's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate LBT's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: LBT is unprofitable, so we can't compare its PE Ratio to the AU Medical Equipment industry average.
PE vs Market: LBT is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate LBT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: LBT is good value based on its PB Ratio (1.3x) compared to the AU Medical Equipment industry average (6.3x).
How is LBT Innovations forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LBT Innovations has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine LBT Innovations's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- LBT Innovations competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has LBT Innovations performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LBT is currently unprofitable.
Growing Profit Margin: LBT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: LBT is unprofitable, and losses have increased over the past 5 years at a rate of 48.2% per year.
Accelerating Growth: Unable to compare LBT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LBT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (37.2%).
Return on Equity
High ROE: LBT has a negative Return on Equity (-23.37%), as it is currently unprofitable.
How is LBT Innovations's financial position?
Financial Position Analysis
Short Term Liabilities: LBT's short term assets (A$7.9M) exceed its short term liabilities (A$1.6M).
Long Term Liabilities: LBT's short term assets (A$7.9M) do not cover its long term liabilities (A$8.0M).
Debt to Equity History and Analysis
Debt Level: LBT's debt to equity ratio (16%) is considered satisfactory.
Reducing Debt: LBT's debt to equity ratio has increased from 6.2% to 16% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LBT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LBT has sufficient cash runway for 3 years if free cash flow continues to reduce at historical rates of 25.4% each year.
What is LBT Innovations's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LBT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LBT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LBT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LBT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LBT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Brenton Barnes, also known as Brent, has been the Chief Executive Officer and Director of LBT Innovations Limited since August 08, 2016. Mr. Barnes has been the Managing Director of LBT Innovations Lim ...
CEO Compensation Analysis
Compensation vs Market: Brent's total compensation ($USD308.35K) is about average for companies of similar size in the Australian market ($USD279.63K).
Compensation vs Earnings: Brent's compensation has increased whilst the company is unprofitable.
|CEO, MD & Director||4.08yrs||AU$420.00k||0.32% |
|CFO & Company Secretary||3.08yrs||AU$184.00k||0.023% |
|Vice President of Global Business Development||7.92yrs||AU$246.00k||0.033% |
|Director of Technology Development||0.083yr||no data||no data|
|Scientific Director||3.75yrs||no data||no data|
|Corporate Development Director||no data||no data||no data|
Experienced Management: LBT's management team is considered experienced (3.8 years average tenure).
|CEO, MD & Director||4.08yrs||AU$420.00k||0.32% |
|Independent Non-Executive Director||8.5yrs||AU$47.00k||0.10% |
|Independent Non-Executive Director||1.67yrs||AU$81.00k||no data|
|Independent Chairman||3.08yrs||AU$81.00k||0.68% |
|Independent Non-Executive Director||1.5yrs||AU$83.00k||0.071% |
Experienced Board: LBT's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.5%.
LBT Innovations Limited's company bio, employee growth, exchange listings and data sources
- Name: LBT Innovations Limited
- Ticker: LBT
- Exchange: ASX
- Founded: 2004
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: AU$38.923m
- Shares outstanding: 288.32m
- Website: https://www.lbtinnovations.com
- LBT Innovations Limited
- 44 Waymouth Street
- Level 8
- South Australia
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|LBT||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jul 2006|
|LBT||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jul 2006|
|LSM||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jul 2006|
LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/17 19:01|
|End of Day Share Price||2020/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.